| Autor: |
Vilas-Boas, Fabrício de Almeida Souza, Silva, Aristóbolo, Sousa, Lirlândia, Lima, Kátia, Vago, Juliana, Bittencourt, Lucas, Dantas, Arthur, Gomes, Dawidson, Vilela, Márcia, Teixeira, Mauro, Barcelos, Lucíola |
| Zdroj: |
Journal of Neuro-Oncology; Apr2016, Vol. 127 Issue 2, p253-260, 8p |
| Abstrakt: |
Malignant gliomas are a lethal type of brain tumors that poorly respond to chemotherapeutic drugs. Several therapy resistance mechanisms have been characterized. However, the response to stress through mRNA translational control has not been evaluated for this type of tumor. A potential target would involve the alpha subunit of eukaryotic translation initiation factor (eIF2α) that leads to assembly of stress granules (SG) which are cytoplasmic granules mainly composed by RNA binding proteins and untranslated mRNAs. We assessed whether glioma cells are capable of assembling SG after exposure to different classes of chemotherapeutic agents through evaluation of the effects of interfering in this process by impairing the eIF2α signaling. C6 and U87MG cells were exposed to bortezomib, cisplatin, or etoposide. Forced expression of a dominant negative mutant of eIF2α (eIF2α) was employed to block this pathway. We observed that exposure to drugs stimulated SG assembly. This was reduced in eIF2α-transfected cells and this strategy enhanced chemotherapeutically-induced cell death for all drugs. Our data suggest that SG assembly occurs in glioma cells in response to chemotherapeutic drugs in an eIF2α-dependent manner and this response is relevant for drug resistance. Interfering with eIF2α signaling pathway may be a potential strategy for new co-adjuvant therapies to treat gliomas. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink